Screening of a population at risk of chronic kidney disease: Analysis of factors associated with low eGFR and microalbuminuria

Renal Failure

Volumn 33, Issue 10, 2011, Pages 969-976

  Ležaić, Vinja ^a,b   Dimković, Nada ^a,b,c   Peković, Gordana Peruničić ^d   Bukvić, Danica ^e   Bajčetić, Sanja ^c   Bontić, Ana ^a   Zec, Nadežda ^d   Pavlović, Jelena ^a   Marinković, Jelena ^b   Dukanović, Ljubica ^f  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Clinical Centre Zvezdara   (Serbia)

^d Clinical centre Zemun   (Serbia)

^e Special Hospital for Endemic Nephropathy   (Serbia)

^f Serbian Medical Society   (Serbia)

Author keywords

Chronic kidney disease; Risk factors; Screening

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIPSTICK MEASUREMENT; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; QUESTIONNAIRE; SCREENING TEST; SMOKING;

AGED; AGED, 80 AND OVER; ALBUMINURIA; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 80054905578     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.615969     Document Type: Article

References (42)

1. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72(3):247-259. (Pubitemid 47172384)
2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298: 2038-2047. (Pubitemid 350074801)
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351: 1296-1305.
4. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489-495. (Pubitemid 41725146)
5. Fried LF, Katz R, Sarnak MJ, et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005;16:3728-3735. (Pubitemid 46211295)
6. Keith D, Nicholls G, Guillion C, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-663. (Pubitemid 38392981)
7. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G. Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis. 1998;32:278-283.
8. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479-486. (Pubitemid 35024618)
9. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39((2) Suppl. 1): S1-S266. Available at: http://www.kidney.org/ professionals/ KDOQI/guidelines-ckd/toc.htm. Accessed November 11, 2010.
10. Joint Specialty Committee of the Royal College of Physicians of London and the British Renal Association. Guidelines for Identification, Management and Referral of Adults with Chronic Kidney Disease. London: Department of Health for England; 2005:20-23. Available at: http://www.renal.org/CKDguide/full/ UKCKDfull.pdf. Accessed November 12, 2010.
11. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14((7) Suppl. 2):S131-S138. (Pubitemid 36750508)
12. Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156-163. (Pubitemid 47012510)
13. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol. 2008;3(2):616-623.
14. Plata R, Silva C, Yahuita J, Perez L, Schieppati A, Remuzzi G. The first clinical and epidemiological programme on renal disease in Bolivia: A model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial Transplant. 1998;13(12):3034-3036. (Pubitemid 28534703)
15. Sumaili EK, Krzesinski JM, Zinga CV, et al. Prevalence of chronic kidney disease in Kinshasa: Results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant. 2009;24(1):117-122.
16. Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in Iran: Prevalence and associated risk factors. J Nephrol. 2009;22:99-108.
17. Singh NP, Ingle GK, Saini VK, et al. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and modification of diet in renal disease equation: An observational, cross-sectional study. BMC Nephrol. 2009;10:4.
18. Ishani A, Grandits GA, Grimm RH, et al. MRFIT Research Group. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol. 2006;17:1444-1452. (Pubitemid 43673426)
19. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: A costeffectiveness analysis. JAMA. 2003;290:3101-3114; Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol. 2008;3(2):616-23. (Pubitemid 37548116)
20. Manns B, Hemmelgarn B, Tonelli M, et al. Alberta kidney disease network. Population based screening for chronic kidney disease: Cost effectiveness study. BMJ. 2010;341:c5869.
21. Chobanian AV, Bakris GL, Black HR, et al. National heart, lung, and treatment of high blood pressure; natonal high blood pressure education, and program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA. 2003;289(19):2560-2572. (Pubitemid 37430158)
22. World Health Organization (WHO). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 2000. WHO Technical Report Series 894.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461-470. (Pubitemid 29135798)
24. Djukanovíc LJ. Benefits of screening for chronic kidney disease. Prilozi. 2010;31(1):249-259.
25. Ležaíc V, Dimkovíc N, Perunícíc G, et al. Results of Belgrade study for early detection of kidney disease.Serbian. In: Djukanovíc LJ, Ležaíc V, Dimkovíc N, eds. Urednici. Monografije Akademije Medicinskih Nauka SLD. Vol. 1. Beograd: Akademije Medicinskih Nauka SLD; 2010:129-148.
26. Kim S, Lim CS, Han DC, et al. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: A population-based cross-sectional epidemiologic study. J Korean Med Sci. 2009;24(Suppl. 1):S11-S21.
27. Chen W, Chen W, Wang H, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant. 2009; 24:1205-1221.
28. Król E, Rutkowski B, Czarniak P, et al. Early detection of chronic kidney disease: Results of the PolNef study. Am J Nephrol. 2009;29(3):264-273.
29. Heidland A, Bahner U, Deetjen A, et al. Mass screening for early detection of renal disease: Benefits and limitations of selftesting for proteinuria. J Nephrol. 2009;22:249-254.
30. Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2003;42: 22-35. (Pubitemid 36807651)
31. Vassalotti JA, Li S, Chen S-C, Collins AJ. Screening populations at increased risk of CKD: The Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis. 2009;53(S3):S107-S114.
32. Obrador GT, Garca-Garca G, Villa AR, et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Màxico and comparison with KEEP US. Kidney Int Suppl. 2010;77(116):S2-S8.
33. Takahashi S, Okada K, Yanai M. The Kidney Early Evaluation Program (KEEP) of Japan: Results from the initial screening period. Kidney Int Suppl. 2010;77(116):S17-S23.
34. Middleton RJ, Foley RN, Hegarty J, et al. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant. 2006;21:88-92. (Pubitemid 43057115)
35. Watanabe Y, Fujii H, Aoki K, Kanazawa Y, Miyakawa T. A cross-sectional survey of chronic kidney disease and diabetic kidney disease in Japanese type 2 diabetic patients at four urban diabetes clinics. Inter Med. 2009;48:411-414.
36. Barrios V, Escobar V,Murga N, et al. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice. J Hypertens. 2008;26(11):2230-2235.
37. Bang H, Vupputuri S, Shoham DA, et al. Screening for occult renal disease (SCORED) simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167:374-381. (Pubitemid 46333938)
38. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata study. Kidney Int. 2006;70(4):751-756. (Pubitemid 44215351)
39. Zhang LX, Zuo L, Xu GB, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant. 2006;22: 1093-1099. (Pubitemid 46523423)
40. Glassock R, Winearls C. Screening for CKD with eGFR: Doubts and dangers. CJASN. 2008;3:1563-1588.
41. Shastri S, Tighiouart H, Katz R, et al. Chronic kidney disease in octogenarians. CJASN. 2011;6:1410-1417.
42. Lepore G, Maglio ML, Nosari I, Dodesini AR, Trevisan R. Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes. Diabetes Care. 2002; 25(11):2103-2104.